Company Profiles

driven by the PitchBook Platform

Direct Flow Medical

Direct Flow Medical
2004 FOUNDED
OOB STATUS
201-300 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Developer of transcatheter aortic heart valve replacement (TAVR) systems designed to treat aortic stenosis. The company's transcatheter aortic heart valve replacement (TAVR) systems offer repeated assessment of full hemodynamic performance before final implantation, enabling heart surgeons to replace human heart valves without invasive surgery.

Ownership Status
Out of Business
Financing Status
Formerly VC-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
451 Aviation Boulevard
Suite 107 A
Santa Rosa, CA 95403
United States

+1 (707) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Direct Flow Medical’s full profile, request a free trial.

Direct Flow Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 21-Dec-2016 00000 Completed Out of Business
7. Later Stage VC (Series A1) 21-Jul-2016 000.00 00000 Completed Profitable
6. Later Stage VC (Series C1) 13-Apr-2016 0000 00000 00000 Completed Profitable
5. Debt - General 18-Feb-2014 0000 00000 Completed Profitable
4. Debt - General 31-Dec-2012 000 000.00 Completed Profitable
3. Later Stage VC (Series C) 16-Apr-2012 000.00 000.00 00000 Completed Profitable
2. Early Stage VC (Series B) 28-Apr-2008 $27.2M $35.8M 000.00 Completed Profitable
1. Early Stage VC (Series A) 16-Oct-2006 $8.65M $8.65M 0000 Completed Profitable
To view this company’s complete deal history including valuation and funding, request access »

Direct Flow Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C1 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
Series C 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 13,865,685 $0.000010 $0.16 $1.96 $1.96 1x $1.96 20.62%
Series A 8,583,141 $0.000010 $0.08 $1 $1 1x $1 12.77%
To view this company’s complete Cap Table, request access »

Direct Flow Medical Executive Team (17)

Name Title Board
Seat
Contact
Info
Chris Richardson International President & Chief Commercial Officer
David Boyle Chief Financial Officer
David Elizondo Chief Operating Officer
Gordon Bishop Chief Technology Officer, Board Member & Founder
Charles Love Vice President, Global Clinical and Medical Affairs

5 Former Executives

You’re viewing 5 of 17 executives. Get the full list »

Direct Flow Medical Board Members (12)

Name Representing Role Since Contact
Info
Evan Norton Self Board Observer 000 0000
Gordon Bishop Direct Flow Medical Chief Technology Officer, Board Member & Founder 000 0000
Stephen Hoffman Self Board Observer 000 0000

9 Former Board Members

You’re viewing 3 of 12 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com